152 related articles for article (PubMed ID: 28738453)
21. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
Luo Z; Li L; Ruan B
Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B vaccination: how to reach risk groups.
François G; Hallauer J; Van Damme P
Vaccine; 2002 Nov; 21(1-2):1-4. PubMed ID: 12443655
[TBL] [Abstract][Full Text] [Related]
23. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
Yang W; Liang X; Cui F; Li L; Hadler SC; Hutin YJ; Kane M; Wang Y
Vaccine; 2013 Dec; 31 Suppl 9():J73-8. PubMed ID: 24331024
[TBL] [Abstract][Full Text] [Related]
24. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B immunization in adolescents.
Lawrence MH; Goldstein MA
J Adolesc Health; 1995 Oct; 17(4):234-43. PubMed ID: 8580124
[TBL] [Abstract][Full Text] [Related]
26. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B immunisation leads to the decline of hepatitis B virus prevalence in Gansu province, China.
Liu C; Li H; Gao L; Li F; Liang X; Yang K
Aust N Z J Public Health; 2011 Feb; 35(1):91-2. PubMed ID: 21299712
[No Abstract] [Full Text] [Related]
28. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
[TBL] [Abstract][Full Text] [Related]
29. Current status of liver diseases in Korea: hepatitis B.
Chae HB; Kim JH; Kim JK; Yim HJ
Korean J Hepatol; 2009 Dec; 15 Suppl 6():S13-24. PubMed ID: 20037275
[TBL] [Abstract][Full Text] [Related]
30. Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).
Beutels P
Health Econ; 2001 Dec; 10(8):751-74. PubMed ID: 11747055
[TBL] [Abstract][Full Text] [Related]
31. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
[No Abstract] [Full Text] [Related]
32. Hepatitis B vaccination in prisons.
Awofeso N
Bull World Health Organ; 2002; 80(7):569-74. PubMed ID: 12163921
[TBL] [Abstract][Full Text] [Related]
33. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.
Yin J; Ji Z; Liang P; Wu Q; Cui F; Wang F; Liang X; Zhuang G
Vaccine; 2015 Jul; 33(31):3731-8. PubMed ID: 26057138
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
35. A hepatitis B-free generation in China: from dream to reality.
Fan R; Yin X; Liu Z; Liu Z; Lau G; Hou J
Lancet Infect Dis; 2016 Oct; 16(10):1103-1105. PubMed ID: 27676339
[No Abstract] [Full Text] [Related]
36. Economic evaluation of universal newborn hepatitis B vaccination in China.
Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R
Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752
[TBL] [Abstract][Full Text] [Related]
37. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.
Zhang L; Xu A; Yan B; Song L; Li M; Xiao Z; Xu Q; Li L
Int J Infect Dis; 2010 Jun; 14(6):e483-8. PubMed ID: 19939719
[TBL] [Abstract][Full Text] [Related]
38. Universal hepatitis B vaccination.
Piazza M
Lancet Infect Dis; 2008 Feb; 8(2):88-9; author reply 90. PubMed ID: 18222158
[No Abstract] [Full Text] [Related]
39. Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
Verma R; Khanna P; Prinja S; Rajput M; Chawla S; Bairwa M
Hum Vaccin; 2011 Dec; 7(12):1387-8. PubMed ID: 22134433
[TBL] [Abstract][Full Text] [Related]
40. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
Sun PP; Zhang SX; Xia Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
